BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
9/19/17 Pfizer (PFE) Sutent for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
9/19/17 Amicus Therapeutics (FOLD) Galafold for Fabry's Disease Subscribers Only Subscribers Only Subscribers Only
9/18/17 GlaxoSmithKline (GSK) Trelegy Ellipta for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
9/18/17 OptiNose Xhance for Nasal Polyposis Subscribers Only Subscribers Only Subscribers Only
9/18/17 Nabriva Therapeutics (NBRV) Lefamulin for Community Acquired Pneumonia (CAP) (Antibacterial) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
09/20/17 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/21/17 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
09/21/17 Subscribers Only Subscribers Only Trial Data - Other
09/21/17 Subscribers Only Subscribers Only Company - Analyst/R&D Update
Now - 09/22/17 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)